Gums have gained acceptance in the pharmaceutical industry as excellent delivery systems for self-medication, especially for the pediatric and geriatric populations when tablets will inhibit patient compliance.
Dow’s AMBERLITE™ and DUOLITE™ ion exchange resin excipients, allow formulators to control the release of drugs in semi-solids including gums.
Solutions for Gums
AMBERLITE™ and DUOLITE™
AMBERLITE™ and DUOLITE™ ion exchange resin excipients can be used in semi-solid dosage forms like chewing gums and lozenges. In these formulations the ion exchange resin controls the release of nicotine for the smoking cessation market.
AMBERLITE™ and DUOLITE™ ion exchange resins can also control the release of drugs in semi-solids like liquid-gels, gummies and lipid based chewy drug delivery systems.